Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent [Phase 4]
Phase 4 trial assessing DARZALEX (daratumumab) in Indian participants with relapsed and refractory multiple myeloma who had prior proteasome…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Bendamustine and Melphalan in Myeloma [Phase 2]
Phase 2 trial evaluating bendamustine plus melphalan in multiple myeloma has completed and posted results on 2025-01-30.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The Effect of Self Acupressure Application on Pain, Fatigue and Sleep Quality in Multiple Myeloma Patients [NA]
This clinical trial evaluated self acupressure for pain, fatigue, and sleep quality in patients with multiple myeloma, and the study has com…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating ixazomib citrate and lenalidomide after stem cell transplant in newly diagnosed multiple myeloma has completed and …
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 2]
A Phase 2 study evaluating maintenance belantamab mafodotin after BCMA-directed CAR T-cell therapy in relapsed or refractory multiple myelom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients [NA]
A terminated clinical trial evaluating acupuncture for chemotherapy-induced peripheral neuropathy in patients with multiple myeloma has post…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML [Phase 1]
The Phase 1 trial of LAVA-051 in relapsed/refractory Chronic Lymphocytic Leukemia, Multiple Myeloma, or Acute Myeloid Leukemia has been term…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab [Phase 2]
An international Phase 2 treatment-extension study of adults with multiple myeloma who have benefited from isatuximab is ongoing (ACTIVE_NOT…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients [Phase 1]
This document provides an update on a Phase 1 autologous memory-like NK cell therapy trial in multiple myeloma using BHV-1100 with low-dose …
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy
A completed clinical trial investigated the role of large extracellular vesicles as biomarkers in various lymphomas and lymphoproliferative …
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Immune Profiling in Multiple Myeloma
An update on a study of immune profiling in multiple myeloma, with the trial status shown as completed.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies [Phase 2]
A Phase 2 trial update reports results for pembrolizumab in relapsed or refractory multiple myeloma after anti-BCMA CAR-T therapy; the study…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy
A completed clinical trial update describes a patient with multiple myeloma treated with belantamab mafotidine as monotherapy.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Determining Normal Range for Free Light Chains in Serum Among Twins [NA]
A completed UCSF clinical trial evaluated the normal range of serum free light chains in twins in the context of multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM [Phase 2]
Phase 2 trial evaluating the addition of isatuximab to CyBorD induction and lenalidomide maintenance in newly diagnosed transplant-eligible …
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 safety and efficacy study evaluating CTX120 in relapsed or refractory multiple myeloma has been terminated. No results are provide…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a daratumumab-based, response-adapted therapy for older adults with newly diagnosed multiple myeloma, with results …
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma [Phase 2]
This is a Phase 2 trial update indicating an out-of-specification (OOS) finding for JNJ-68284528 intended for commercial release in particip…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma [Phase 3]
Phase 3 trial comparing Daratumumab with Velcade, Lenalidomide, and Dexamethasone versus Velcade, Lenalidomide, and Dexamethasone in previou…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors [Phase 1, Phase 2]
An update on the Phase 1/2 study of CYT-0851 in B-cell malignancies and advanced solid tumors, noting completion of Phase 1/2 cohorts.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: A Safety Study of SEA-BCMA in Patients With Multiple Myeloma [Phase 1]
Phase 1 safety study of SEA-BCMA in patients with multiple myeloma was terminated. Results were posted on 2024-12-24.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma [Phase 2]
Phase 2 trial evaluating dendritic cell therapy for acute myeloid leukemia, chronic myeloid leukemia, and multiple myeloma reports efficacy …
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia [EARLY_Phase 1]
Early-phase 1 clinical trial of CT0596 for relapsed/refractory multiple myeloma and relapsed/refractory plasma cell leukemia is currently re…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
This clinical trial investigated the role of extracellular NAMPT (eNAMPT) in the biology and progression of multiple myeloma; the study has …
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A) [Phase 2]
Phase 2 MATCH subprotocol evaluating afatinib for cancers with EGFR genetic alterations; results have been posted and the trial is active bu…